Leap Investments’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-664
Closed -$114K 486
2019
Q2
$114K Buy
+664
New +$114K 0.15% 199